CA2294342C - Process for synthesizing carbapenem side chain intermediates - Google Patents

Process for synthesizing carbapenem side chain intermediates Download PDF

Info

Publication number
CA2294342C
CA2294342C CA002294342A CA2294342A CA2294342C CA 2294342 C CA2294342 C CA 2294342C CA 002294342 A CA002294342 A CA 002294342A CA 2294342 A CA2294342 A CA 2294342A CA 2294342 C CA2294342 C CA 2294342C
Authority
CA
Canada
Prior art keywords
compound
formula
accordance
produce
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002294342A
Other languages
French (fr)
Other versions
CA2294342A1 (en
Inventor
Karel M. J. Brands
John M. Williams
Ulf H. Dolling
Ronald B. Jobson
Antony J. Davies
Ian F. Cottrell
Mark Cameron
Michael S. Ashwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810184.3A external-priority patent/GB9810184D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CA2294342A1 publication Critical patent/CA2294342A1/en
Application granted granted Critical
Publication of CA2294342C publication Critical patent/CA2294342C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)

Abstract

A process of synthesizing a compound of formula (1) is described. A compound of formula (2) is reacted with diphenylphosphinic chloride to activate the carboxylic acid group, and then reacted with methanesulfonyl chloride to produce a compound of formula (4). Compound (4) is then reacted with a group II metal sulfide source in water to produce a compound of formula (1).

Description

TITLE OF THE INVENTION
PROCESS FOR SYNTHESIZING CARBAPENEM
SIDE CHAIN INTERMEDIATES
BACKGROUND OF THE INVENTION
The present invention relates to the synthesis of carbapenem side chains, and in particular, to side chains or portions thereof containing a pyrrolidine group, which is bonded to the carbapenem nucleus through a thioether linkage. Typically, the pyrrolidine is a portion of the side chain, and is substituted at the two position with any of a variety of substituents.
Conventionally, these intermediate compounds are prepared from a 4-hydroxyproline derivative of the formula:
HO
CONR~R2 N
R
Such synthetic schemes typically require the extensive use of protecting groups.
Similarly, a method of converting trans-4-hydroxy-L-proline to a thiolactone of the formula:
O
S
N
C(O)CH3 has been described. However, this thiolactone is unsuitably protected for synthesis of carbapenem antibiotics.
EP 551 993 Al published on July 21, 1993 relates to a synthesis which utilizes active esterifying agents and base, followed by treatment with hydrogen sulfide, or an alkali metal salt of hydrogen sulfide, and base.
The present invention is an improvement over these other processes, utilizing a sulfide source which surprisingly improves the process when commercial quantities are synthesized.
SUMMARY OF THE INVENTION
A process for synthesizing a compound of the formula 1:
p O

is described wherein P is a protecting group comprising (a) reacting a compound of formula 2:
H 0,,,~,, I
P

wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of formula 3:
HO,,,~,,.
N C~O~P
O p ' /

(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
H3CSO3 0,,~,,, ~C,O~P
Ipl II
P O
and (c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
More particularly, the process described herein relates to a process for producing a compound of the formula 5:
HS
'~C(O)NR'Rz N
P
wherein P is a protecting group;
R~ and R2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of:
C 1 _q. alkyl, C ~ _4 alkoxy, C 1 _4 alkylthio, halo, hydroxy, C02H, C02C1_4 alkyl, NH2, NHCl_4 alkyl, N(Cl_4 alkyl)2, S03H, CN, NHC(O)C1_4 alkyl, S02NH2, S02C1_4 alkyl, aryl and heteroaryl;
comprising: (a) reacting a compound of the formula 2:
H 0,,,,,,.
~C02H
N
P

wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3:
HO,,,,,, ~C.O~P
ii II
P O O

(b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
H3CSO3 gin,,,,, C.O~P
P O O

(c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1:
P O

and (d} reacting compound 1 with NHR1R2 wherein R~ and R2 are as previously defined to produce a compound of formula 5:
DETAILED DESCRIPTION OF THE INVENTION
The invention is described using the following definitions unless otherwise specified.
Alkyl and the alkyl portions of substituent groups include monovalent hydrocarbon chains containing from 1-4 carbon atoms which are straight or branched as appropriate.
Aryl refers to 6-10 membered mono- and bicyclic ring systems, containing carbon atoms with alternating (resonating) double bonds. Preferred aryl groups are phenyl and naphthyl.
Heteroaryl refers to aromatic 5-10 membered mono- and bicyclic ring systems, containing from 1-4 heteroatoms, O, S or N.
Preferred nitrogen containing monocyclic heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl and l, 2, 4-triazolyl. Preferred heteroaryl groups containing oxygen as the only heterotom include furanyl. Preferred heteroaryl groups containing sulfur as the only heterotom include thienyl.
Preferred bicyclic heteroaryl groups include benzthiazolyl, benzimidazolyl, quinolinyl and isoquinolinyl, indolyl and isoindolyl.
When substituted, the aryl and heteroaryl groups may be substituted with 1-3 groups selected from the group consisting of: Cl-4 alkyl, C 1-4 alkoxy, C 1 _4 alkylthio, halo, hydroxy, C02H, C02C 1 _4 alkyl, NH2, NHC 1 _4 alkyl, N(C 1 _4 alkyl)2, NHC(O)C 1 _4 alkyl, S03H, CN, S02NH2, S02C1-4 alkyl, aryl and heteroaryl.
When necessary, the substituents which are optionally present on aryl and heteroaryl can be in protected form.
Examples of suitable protecting groups include the following without limitation: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyl-oxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethyl-silyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C,_,o alkylphosphoryl, diarylphosphoryl and di-ar-C,_,o alkylphosphoryl. Preferred silyl protecting groups are trimethylsilyl and triethylsilyl. Preferred carboxyl protecting groups are p-nitrobenzyl and allyl. Preferred phosphoryl based protecting groups include diisopropylphosphoryl.
Many other suitable hydroxyl and carboxyl protecting groups are known in the art. See, e.g., Greene, T. W., et al. Protective Groups in Or anic Synthesis, John Wiley & Sons, Inc., 1991.
P represents a protecting group on the proline nitrogen atom.
Thus, in one aspect of the invention, P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenyl-silyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitro-_7_ benzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl) ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C,-,o alkylphosphoryl, diarylphosphoryl and di-ar-C,_,o alkylphosphoryl.
More particularly, P represents a protecting group which is selected from the group consisting of: t-BOC, diisopropylphosphoryl and p-nitrobenzyloxycarbonyl.
Most particularly, P represents diisopropylphosphoryl.
Compound 2 used herein as a starting material is N
protected trans-4-hydroxy-L-proiine. The 2-carboxyl group is activated using the compound diphenylphosphinic chloride, which is reacted with I S compound II in a solvent in the presence of excess base. Solvents which are useful herein include dichloromethane, acetonitrile, toluene, fluorobenzene, tetrahydrofuran, or mixtures thereof. Bases which are useful for this reaction include trialkylamines. Preferred trialkylamines include diisopropylethylamine (DIPEA) and triethylamine.
Typically an amount of diphenylphosphinic chloride which is about equimolar to the starting compound can be used. The reaction between compound 2 and diphenylphosphinic chloride is typically run at reduced temperature, below about 0°C to as low as about -40°C.
Preferably, the reaction temperature is maintained at about -10°C.
Compound 3, with the diphenylphosphinyloxycarbonyl group at position two, is reacted with methanesulfonyl chloride (MsCl) to produce compound 4. This reaction is conducted in a solvent, in the presence of a slight molar excess of pyridine, collidine, lutidine and the like, using a slight molar excess of MsCI. This mesylation reaction may be conducted over about 1-4 hours, at a reduced temperature, e.g., about 0°C to as low as about -40°C. Preferably, the reaction temperature is maintained at about -10°C.
Compound 4 is thereafter combined with an alkali metal sulfide or non-alkali metal sulfide and water to form the thiolactone 1.

_g_ Essentially the reaction can be conducted at about -10°C to about room temperature. Preferably the sulfide and water are added quickly, and the reaction is aged for several hours at ambient temperature.
As used herein, "alkali metal sulfide" refers to the group I
metal sulfides, such as the sulfides of sodium and potassium. Preferably the alkali metal sulfide is Na2S.
As used herein, "non-alkali metal sulfides" and "alkaline earth metals" are used interchangeably to include the group II alkaline earth metal sulfides selected from the group consisting of: magnesium, calcium and barium. Preferred are calcium and barium.
The preferred non-alkali metal sulfide, most notably CaS, provides an unexpected advantage in that side products of the reaction have low solubility in water, and thus can be removed as a precipitate.
In a preferred aspect of the process described herein, the amine HNR'RZ is m-aminobenzoic acid.
In another preferred aspect of the process, the compound of formula 5 is reacted with an acid to produce a compound of formula 6:
HS
~C(O)NR~R2 N
H

More particularly, a compound of formula 2' H 0,,, N
P(O)(OiPr)2 2' is reacted with diphenylphosphinic chloride to produce a compound of formula 3' H 0,,, .~C02P(O)(Ph)2 N
P(O)(OiPr)2 3' compound 3' is reacted with mesyl chloride to produce compound 4' MsO,,, .~ C02P(O)(Ph)2 N
P(O)(OiPr)2 4' compound 4' is reacted with a member selected from the group consisting of: Na2S, K2S, CaS and BaS to produce a compound of formula 1':
(iPrO)2P(O) ~N~~!~O
S
1' compound 1' is reacted with m-aminobenzoic acid to produce 5' HS
?--~C(O)NH
N
P(O)(OiPr)z s' and compound 5' is reacted with acid to produce a compound of formula 6' HS
'~C(O)NH
N
H
6' or a salt or solvate thereof.

10a -In a preferred aspect of the invention, the thiolactone compound 1 is reacted with the amine HNR1R2 in the presence of an organic acid to produce compound 5. Examples of suitable organic acids include formic acid, acetic acid and propionic acid. Most preferably, the reaction is conducted in the presence of acetic acid. Preferably, this reaction is carried out in the presence of an organic solvent, such as methylene chloride.
After the conversion of compound 4' to compound 1', the latter is combined with ammonia or a primary or secondary amine to form compounds of formula 5', which can be deprotected to give compound 6' or salt thereof. In the isolation of 6' solvents, such as C~_5 alcohols, C1_3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others may be added to improve crystallization, or otherwise facilitate isolation.

Also, addition of a trialkyl or triaryl phosphine, e.g., tri-n-butylphosphine, at this stage may be useful in reducing the formation of disulfides corresponding to compound (' and/or improving the rejection of other impurities.
Most primary and secondary amines HNR1R2 wherein Rl andlor RZ represent H, aryl or heteroaryl react with compound 1 upon slight heating. Generally, the reaction proceeds from about RT to about 100°C over a few minutes to several hours.
The acid that is used to convert compound 5' to compound G' can be varied within wide limits. For example, concentrated HCl can be used and is preferred.
The invention described herein can be conducted in essentially a single reaction vessel, thus allowing for economical production of compounds 6' from compound 2.
The invention is further illustrated with the following non-limiting examples.
EXAMPLE ONE
~1 S. 4S~-5-DIISOPROPYLPHOSPHORYL-2-THIA-5-AZAB ICYCLO f 2.2.11 HEPTAN-3-ONE
HO,,,,.
N/ _ CO H diphenylphosphinic 2 chloride P(O)(OiPr)2 HO,,,,, O
methanesulfonyl P \ ~ chloride P(O)(OiPr)2 MsO,,,,, O
CO2 P \ / CaS/H20 Slurry 1_4 ~ \
P(O)(OiPr)2 (iPrO)2(O)P~ O

The following starting materials were utilized:
Startin Material uantit Diisopropylphosphoryl 5.0 g, 16.93 mmol h drox roline Diiso ro leth lamine 6.34 mL, 36.44 mmol Diphenylphosphinic 3.36 mL, 17.61 mmol chloride P ridine 1.48 mL, 18.29 mmol Methanesulfon 1 chloride1.43 mL, 18.46 mmol Calcium sulfide 1.49 , 20.66 mmol Dichloromethane 100 mL

Water 350 mL

The mesylate mixed anhydride was formed according to WO 97/06154 published on February 20, 1997, incorporated herein by reference, and stirred with cooling at -15°C for 15 min.
Calcium sulfide (1.49 g) was added as a solid and washed with water (30 mL), resulting in a three phase reaction mixture. The mixture was stirred rapidly and the cooling bath removed, allowing the mixture to reach room temperature.
r The solids quickly went into solution, and a white solid precipitate was formed.
The mixture was stirred for 45 min and then filtered through a coarse filter. The solid on the filter was washed with dichloromethane and the filtrate separated.
The organic layer (approx. 200 mL) was washed with 1 M
HCl (50 mL), and 8% NaHC03 (50 mL). The aqueous bicarbonate layer was back extracted and the combined extracts were washed with brine and the layers weighed. The presence of the title compound (4.04 g) was confirmed by HPLC.
EXAMPLE TWO
HO,,~I
~ H diphenylphosphinic N chloride t-BOC O

HO,,~,. O
methanesulfonyl chloridc N
t-BOC O

MsO,,,, O
O-P \ ~ CaS
--N ~ \ H2o t-BOC O

t-BOC O

A. Synthesis of trans-N-t-butoxycarbonyl-2-dinhenylphosphinyloxvcarbonyl-4-h~~~roline H 0,,~,I DIpEA
OH dry THF
-2o°c diphenylphosphmic t-BOC ~ chloride HO
O-P~ \
II
o b A solution of compound 2-2 (35.0 g, 151 mmol.) and DIPEA
(60 mL, 344 mmol) in dry THF ( 1.0 L) was combined over 20 min with a solution of diphenylphosphinic chloride (37.5 g, 155 mmol) in THF (50 mL) at -20°C. The reaction mixture was stirred at -20°C for 90 minutes to produce compound 2-3, which can be isolated and characterized or used in the next part without isolation.
B. Synthesis of trans-N-t-butoxycarbonyl-2-diphenylphosphinyl oxycarbonyl-4-methanesulfonxloxy-L-proline HO,,,, O
\ ~ methanesulfonyl 0-P chloride N ~ ~ \
t-BOC O

MsO, O-P~ \
II
o b Without isolation and characterization, after stirring the reaction mixture from part A for 90 minutes at -20°C, pyridine (13.0 mL, 161 mmol) was added followed by a solution of methanesulfonyl chloride ( 19.8 g, 171 mmol) in THF (50 mL) over 15 minutes. The reaction mixture was stirred at -20°C for 2 hours and allowed to warm to -5°C
over an additional 30 minutes producing compound 2-4. The methanesulfonyl substituted compound can be isolated and characterized, or used in the next reaction without isolation and characterization.

C. Synthesis of N-t-butoxycarbonyl-2-thia-5-azabicyclo[2.2.1]heptan-3-one MsO,,,, O
O-P \ ~ CaS/H20 \ Slurry t-BOC O

t-BOC O

After allowing the reaction from part B to warm to -5°C, a slurry of CaS (45.0 g, 187 mmol) in H20 (60 mL) is added in one portion. The mixture is allowed to warm to room temperature and is stirred for 6 hrs. The resulting suspension is filtered and the filtrate is then partitioned between toluene and water. The organic Iayer is washed with HCl (2.0 M), NaHC03 ( 1.0 M) and brine, dried over MgS04 and concentrated in vacuo.
EXAMPLE THREE
HS
t-BOC O
~C(O}NR 1 R2 N

t-BOC

The thiolactone 2-1 from Example Two without isolation, can be combined with the amine shown below in column one to produce the cis N-protected 4-thiol substituted proline derivative shown below in column two.
TABLE ONE
Amine Product (3) (3_1) HS
NH4Cl ~''C(O)NH2 N
i t-BOc (3-2) HS
NH2 ~C(O)NH
N
I
t-BOC

(3-3) ~C(O)NH ~

C02H t-BOC

-1$-(3-4) HS
~C(O)NH

H2N ~S ~C02H
t-BOC

(3-5) HS
NH2 ~C(O)NH ~

t'(O)(OiPr) (1) 4.0 eq. of NH4C1 in Et3N; solvent CH30H;
reaction time: 30 min at RT;
(2) 1.25 eq. of aniline; solvent toluene; reaction time:
2 hrs at 100°C;
(3) 1.25 eq. of 3-aminobenzoic acid; solvent toluene;
reaction time: 2 hrs at 100°C;
(4) 1.25 eq. of 5-amino-2-carboxythiophene; solvent toluene; 2 hrs at 100°C;
(5) P represents diisopropylphosphoryl. (iPr = isopropyl).
EXAMPLE FOUR
Using the procedures set forth in Example Two, Part A, the compounds of column one are reacted with diphenylphosphinic chloride to produce the compounds in column two.

TABLE TWO
HO,,,,,,, HO,,,, C02P(O)(Ph)2 N
O~O ~ O O

N02 ph - phenyl HO~~,,,, HO,,,,,, C02H ~ C02P{O)(Ph)2 N N
\ ~O \
O O ~ O
/ /

HO,,,,,,, HO,,,~,.
~'C02H ~C02P(O)(Ph)2 N N

SUBSTITUTE SHEET (RULE 26) EXAMPLE FIVE
Using the procedures set forth in Example One, Part B, the compounds of column one are reacted with methanesulfonyl chloride to produce the compounds in column two.
TABLE THREE

MsO,, ~C02P(O)(Ph)2 O~O

Ph = phenyl 4-3-2 MsO,,,,, ~
C02P(O)(Ph)2 N
O~O

MsO,,,,,,, ~C02P(O)(Ph)2 N
~O~
O
EXAMPLE SIX
Using the procedures set forth in Example Two, Part C, the compounds of column one are reacted with CaS in water to produce the compounds in column two.
TABLE FOUR

NOZ
w OII
Ol~N. / O
S

5_4.2 OII
OJ~N.~O
I S
fi-1-3 OJ~N / O
S
EXAMPLE SEVEN
Using the procedures set forth in Example Three, the compounds of column one are reacted with the amine in column two to produce the compounds in column three.

TABLE FIVE
Amine NHR1R2 P rrolidine 7_5_1 1 HS
(1) ~C(O)NH2 6-1-1 NH4Cl N
\
O
(2) . H S
NH2 ~C(O)NH-Ph ~O \
/ O

Ph = Phenyl (3) HS
NH ~C(O)NH

\ C02H
O~O

7_5_4 1 (4) H S
~C(O)NH
N s C02H

H2N S C02H O'~'O \

HS
(1) 6-1-2 ~C(O)NH2 NH4Cl N
O
7_5_6 1 (2) HS
6-1-2 NH2 ~C(O)NH-Ph N
/ p p /
Ph = Phenyl 7_5_7 1 (3) HS
._ 6-1-2 NH2 ~C(O)NH
N
O ~ C02H

7_5_8 1 (q.) H S
~C(O)NH

H2N S/\C02H O~O w 7_5-9 1 HS
(1) ~C(O)NH2 6-1-3 ~ NH4Cl N
~O~
O

(2) HS
NH2 ~'~'C(O)NH-Ph / O O~
Ph = Phenyl 7-5-11 l (3) HS
NH ~'C(O)NH
N
6-1-3 l O~ C02H
/ O

(4) 7-5-12 1 HS
- _ ~ , C(O)NH ~ I
613 H2N S~C02H N S~C02H
O~O
(3) 7-5-13 ' 1-1 ~ ~C(O)NH ~
I / N
CO H
CO H ~(O)(piPr) 1: Tri-n-butylphosphine may be added.
While certain preferred embodiments have been described herein in detail, numerous alternative embodiments are contemplated as falling within the scope of the invention.

Claims (30)

1. A process for synthesizing a compound of the formula 1:
wherein X is a protecting group selected from the group consisting of:
t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C 1-10 alkylphosphoryl, diarylphosphoryl and di-ar-C 1-10 alkylphosphoryl, comprising (a) reacting a compound of the formula 2:
:wherein X is as defined above with diphenylphosphinic chloride in a solvent in the presence of excess base to produce a compound of the formula 3:
(b) reacting said compound 3 with methanesulfonyl chloride in a solvent in the presence of a slight molar excess of pyridine, collidine or lutidine to produce a compound of formula 4:
(c) combining said compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of said formula 1.
2. A process of producing a compound of the formula 5:

wherein X is a protecting group selected from the group consisting of:
t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C 1-10 alkylphosphoryl, diarylphosphoryl and di-ar-C 1-10 alkylphosphoryl, R1 and R2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, halo, hydrogen, CO2H, CO2C1-4 alkyl, NH2, NHCl4 alkyl, N(C1-4 alkyl)2, SO3H, CN, NHC(O)C1-4 alkyl, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl; comprising: (a) reacting a compound of the formula 2:
wherein X is as defined above with diphenylphosphinic chloride in a solvent in the presence of excess base to produce a compound of the formula 3:
(b) reacting said compound 3 with methanesulfonyl chloride in a solvent in the presence of a slight molar excess of pyridine, collidine or lutidine to produce a compound of formula 4:
(c) combining said compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1:

(d) reacting said compound 1 with NHR1R2 wherein R1 and R2 are as defined above to produce a compound of said formula 5.
3. A process in accordance with claim 1 or 2, wherein X is selected from t-BOC, p-nitrobenzyloxycarbonyl and diisopropylphosphoryl.
4. A process in accordance with claim 3 wherein X represents diisopropylphosphoryl.
5. A process in accordance with claim 2 wherein said compound 1 and said NHR1R2, in (d) are reacted in the presence of an organic acid to produce said compound of formula 5.
6. A process in accordance with claim 5 wherein the organic acid is selected from formic acid, acetic acid and propionic acid.
7. A process in accordance with claim 5 wherein said compound 1 and said NHR1R2 in (d) are reacted in an organic solvent.
8. A process in accordance with claim 7 wherein the organic solvent is methylene chloride.
9. A process in accordance with claim 1 or 2, wherein the base in (a) is a trialkylamine.
10. A process in accordance with claim 9 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine.
11. A process in accordance with claim 1 or 2, wherein said compound 3 is reacted with said methanesulfonyl chloride in the presence of pyridine to produce said compound of formula of formula 4.
12. A process in accordance with claim 1 or 2, wherein said compound 3 is reacted with said methanesulfonyl chloride in the presence of collidine to produce said compound of formula of formula 4.
13. A process in accordance with claim 1 or 2, wherein said compound 3 is reacted with said methanesulfonyl chloride in the presence of lutidine to produce said compound of formula of formula 4.
14. A process in accordance with claim 1 or 2, wherein said compound 4 is reacted with a non-alkali metal sulfide to produce said compound of formula 1.
15. A process in accordance with claim 14 wherein the non-alkali metal sulphide, in water, is reacted with said compound 4 to produce said compound of formula 1 at a temperature of 10°C to room temperature.
16. A process in accordance with claim 2 wherein NHR1R2 is selected from the group consisting of:

17. A process in accordance with claim 14 or 15 wherein the non-alkali metal sulfide is selected from a sulfide of calcium, barium and magnesium.
18. A process in accordance with claim 17 wherein the non-alkali metal sulfide is calcium sulfide.
19. A process in accordance with claim 17 wherein the non-alkali metal sulfide is barium sulfide.
20. A process in accordance with claim 1 wherein:
X represents diisopropylphosphoryl and said compound 4 is reacted with CaS in water to produce a compound of said formula 1.
21. A process in accordance with claim 1 wherein:
X represents diisopropylphosphoryl and said compound 4 is reacted with Na2S
in water to produce a compound of said formula 1.
22. A process in accordance with claim 2 wherein the amine HNR1R2 is m-aminobenzoic acid.
23. A process in accordance with claim 2, further comprising reacting a compound of formula 5 with an acid to produce a compound of formula 6:
24. A process in accordance with claim 23 in which said reacting of said compound of formula 5 with an acid is in the presence of trialkylphosphine or triarylphosphine.
25. A process in accordance with claim 24 in which the trialkylphosphine is tri-n-butylphosphine.
26. A process in accordance with claim 23 in which the reacting is in a solvent selected from the group consisting of C 1-5 alcohols, C 1-3 alkanoic acids, toluene, acetonitrile and ethyl acetate.
27. A process in accordance with claim 23, wherein said compound of formula 2 is a compound of formula 2':

and is reacted with said diphenylphosphinic chloride to produce said compound of formula 3 which is a compound of formula 3':
said compound 3' is reacted with mesyl chloride to produce said compound of formula 4 which is a compound of formula 4':
said compound 4' is reacted with a member selected from the group consisting of Na2S, K2S, CaS and BaS to produce a compound of formula 1':

said compound 1' is reacted with m-aminobenzoic acid to produce said compound of formula 5 which is a compound of formula 5':
and said compound 5' is reacted with acid to produce said compound of formula 6 which is a compound of formula 6':
or a salt or solvate thereof.
28. A process in accordance with claim 27 in which said reacting of said compound 5' with acid is in the presence of trialkylphosphine or triarylphosphine.
29. A process in accordance with claim 28 in which the trialkylphosphine is tri-n-butylphosphine.
30. A process in accordance with claim 28 or 29 in which said reacting of said compound 5' with acid is in the presence of a solvent selected from the group consisting of C 1-5 alcohols, C 1-3 alkanoic acids, toluene, acetonitrile and ethyl acetate.
CA002294342A 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates Expired - Fee Related CA2294342C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5203297P 1997-07-09 1997-07-09
US60/052,032 1997-07-09
GBGB9810184.3A GB9810184D0 (en) 1998-05-13 1998-05-13 Process for synthisizing carbapenem side chain intermediates
GB9810184.3 1998-05-13
PCT/US1998/013738 WO1999002531A1 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Publications (2)

Publication Number Publication Date
CA2294342A1 CA2294342A1 (en) 1999-01-21
CA2294342C true CA2294342C (en) 2006-03-14

Family

ID=26313663

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002294342A Expired - Fee Related CA2294342C (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Country Status (5)

Country Link
EP (1) EP1019411A4 (en)
JP (1) JP2002504156A (en)
AU (1) AU731586B2 (en)
CA (1) CA2294342C (en)
WO (1) WO1999002531A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
WO2001064684A1 (en) * 2000-03-01 2001-09-07 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
ATE315568T1 (en) * 2000-11-20 2006-02-15 Sankyo Co METHOD FOR PRODUCING CARBAPENEM-TYPE ANTIBACTERIAL COMPOUNDS
SG169238A1 (en) 2004-08-11 2011-03-30 Williamsburg Holdings Llc Noncardiotoxic pharmaceutical compounds
WO2010073706A1 (en) * 2008-12-25 2010-07-01 株式会社カネカ Improved process for producing intermediate for side chain of carbapenem
CN106565579A (en) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 Ertapenem side chain production technology

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP3091297B2 (en) * 1992-01-10 2000-09-25 住友製薬株式会社 Pyrrolidine derivative and method for producing the same
ATE197456T1 (en) * 1995-08-04 2000-11-11 Merck & Co Inc METHOD FOR PRODUCING CARBAPENEM SIDE CHAIN INTERMEDIATE PRODUCTS

Also Published As

Publication number Publication date
JP2002504156A (en) 2002-02-05
CA2294342A1 (en) 1999-01-21
AU8282198A (en) 1999-02-08
EP1019411A4 (en) 2003-08-13
WO1999002531A1 (en) 1999-01-21
AU731586B2 (en) 2001-04-05
EP1019411A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
US4631150A (en) Process for the preparation of penems
CA2294342C (en) Process for synthesizing carbapenem side chain intermediates
CA2227696C (en) Process for synthesizing carbapenem side chain intermediates
US6063931A (en) Process for synthesizing carbapenem side chain intermediates
AU605491B2 (en) Quaternary amine thiol process
US6060607A (en) Process for synthesizing carbapenem side chain intermediates
KR950013578B1 (en) Novel reactive thiophosphate derivatives of thia(dia)zole acetic acid and process for preparing the same
EP0557122A1 (en) A production method for sulfamide
US5574155A (en) Process for the synthesis of the disodium salt hemiheptahydrate of ceftriaxone
US5648501A (en) Process for synthesizing carbapenem side chain intermediates
PL145176B1 (en) Process for preparing derivatives of penemo-2-carboxylic-3-acid
US5721368A (en) Process for synthesizing carbapenem side chain intermediates
KR20050086548A (en) Process for producing carbapenem compound for oral administration
KR100298922B1 (en) Method for preparing 4-substituted azetidinone derivatives
JP2696807B2 (en) Preparation of carbapenem derivatives
KR100650207B1 (en) Glutaryl 7-amino-3-vinyl-cephalosporanic acid derivatives and process for preparing it
US5580976A (en) Preparation of β-lactam compounds, and intermediates therefor
SE445738B (en) PROCEDURE FOR PREPARING A 3-CARBAMOYLOXIMETHYL Cephalosporin Compound
KR950013571B1 (en) Process for the preparation o(6r,7r)-7-£(z)-2-(2-aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)ace tamido|-3-(1-pyridiniommethyl)ceph-3-em-4-carboxylate 2 hydrochloride salt
US4082745A (en) Process for the preparation of phosphorus derivatives of secondary ammonium salts of penam and cephem compounds
US20060281918A1 (en) Resolution of enantiomeric mixtures of beta-lactams
HU192983B (en) Process for production of cefem compounds
KR20040019540A (en) A highly efficient synthetic process for the preparation of simvastatin and new intermediates therefor
JPH06271546A (en) Production of imidazolidine derivative
JPH0717644B2 (en) (1R) -1-substituted carbapenem-3-carboxylic acid derivative

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed